SAN FRANCISCO--(BUSINESS WIRE)--As the Drug Information Association (DIA) Annual Meeting begins, Mosio, Inc. announced a suite of solutions created specifically for each type of organization within the clinical research ecosystem.
Mosio’s web-based mobile messaging software services to enhance clinical trial recruitment and retention range from targeted plans for principal investigators and study sites; to broad capabilities for CROs; and fully customizable solutions for integration into study platforms of study sponsors, patient recruitment firms, and trial technology enterprises. All Mosio services utilize its award winning two-way text messaging platform, shown to be a strategic and powerful patient recruitment, retention and engagement tool to connect with clinical trial participants on the devices they use every day.*
“Leveraging our experience in delivering custom clinical research solutions, the Mosio team has created a suite of text message-based clinical trial tools that improve study enrollment and patient retention success, tailored specifically to the varying needs of research sites, CROs, sponsors, and patient recruitment firms,” explained Noel Chandler, Co-Founder and CEO of Mosio.
“The recent expansion of the Mosio team – adding key expertise in clinical operations, technology development and project management – enables us to easily customize our software for the needs of organizations seeking patient engagement solutions on mobile’s most popular channel, text messaging,” Chandler added.
Plans for Principal Investigators/Study Sites
Service plans include SMS features to improve operational efficiencies such as appointment reminders and leveraging patient databases to improve study enrollment.
Plan for CROs/SMOs
Mosio provides a full suite of SMS capabilities to help recruit, retain and motivate patients in trials, with interactive features to assist with protocol compliance requirements such as medication and study adherence.
Sponsors/Enterprise Custom Plan
This option includes all Mosio SMS capabilities and configuration of the platform to specific requirements, integrating into the client’s platforms to enable text messaging functionally for all aspects of clinical trials. Provided through custom configured RESTful APIs, solutions can be developed for large, multi-site studies or systems integration into third party software for seamless data and workflow between software providers.
About Mosio, Inc.
Mosio’s award-winning mobile messaging platform enables researchers to recruit and retain study participants through text message alerts, reminders, surveys and interactive “TextChat” features. Mosio’s True Two-Way Text Messaging platform includes capabilities in over 40 countries and utilizes its Merge Field Technology which enables the infusion of flexible data sets into messages to provide a more personalized element of patient communications.
* M. Alsumidaie, Text Messaging: Enhancing Clinical Trial Patient
Recruitment and Enrollment,
Applied Clinical Trials, Nov. 3, 2014.